The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2)

International Journal of Stroke

Volumn 5, Issue 2, 2010, Pages 110-116

  Delcourt, C ^a   Huang, Y ^b   Wang, J ^c   Heeley, E ^a   Lindley, R ^d   Stapf, C ^e,f   Tzourio, C ^f   Arima, H ^a   Parsons, M ^g   Sun, J ^h   Neal, B ^a   Chalmers, J ^a   Anderson, C ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d UNIVERSITY OF SYDNEY   (Australia)

^e HÔPITAL LARIBOISIÈRE   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g UNIVERSITY OF NEWCASTLE   (Australia)

^h George Institute   (China)

Author keywords

Blood pressure; Clinical trial; Hypertension; INTERACT; Intracerebral haemorrhage; Stroke

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDRALAZINE; LABETOLOL; METOPROLOL; NICARDIPINE; UNCLASSIFIED DRUG; URAPIDIL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; EARLY INTERVENTION; FEASIBILITY STUDY; FUNCTIONAL STATUS; HEALTH CARE POLICY; HEALTH PROGRAM; HEMATOMA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SAFETY; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RECURRENT DISEASE; REPEATED DRUG DOSE; RISK BENEFIT ANALYSIS; RISK FACTOR; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT INDICATION;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; PATIENT SELECTION; PROSPECTIVE STUDIES; SAMPLE SIZE; STROKE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951225258     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00415.x     Document Type: Article

References (22)

1. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003, 2:43-53.
2. Saposnik G, Del Brutto OH. Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke 2003, 34:2103-7.
3. Zhang LF, Yang J, Hong Z. Proportion of different subtypes of stroke in China. Stroke 2003, 34:2091-6.
4. Mayer SA, Brun NC, Begtrup K. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358:2127-37.
5. Mendelow AD, Gregson BA, Fernandes HM. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 2005, 365:387-97.
6. Wang WZ, Jiang B, Liu HM. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke 2009, 4:11-6.
7. Morgan T, Awad I, Keyl P, Lane K, Hanley D. Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir 2008, 105((Suppl.)):217-20.
8. Lawes CM, Rodgers A, Bennett DA. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003, 21:707-16.
9. Lawes CM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke 2004, 35:1024-33.
10. Robinson TG, Potter JF. Blood pressure in acute stroke. Age Ageing 2004, 33:6-12.
11. Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004, 43:18-24.
12. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004, 35:1364-7.
13. Zhang Y, Reilly KH, Tong W. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens 2008, 26:1446-52.
14. Broderick J, Connolly S, Feldmann E. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007, 38:2001-23.
15. Steiner T, Kaste M, Forsting M. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis 2006, 22:294-316.
16. Anderson CS, Huang Y, Wang JG. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008, 7:391-9.
17. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974, 2:81-4.
18. Brott T, Adams HP, Olinger CP. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864-70.
19. Bamford JM, Sandercock PA, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989, 20:828.
20. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33:337-43.
21. MIStar User Manual Melbourne., Apollo Medical Imaging Technology Pty Ltd, 2007
22. Davis SM, Broderick J, Hennerici M. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006, 66:1175-81.